PsyRX CNS Bio-Tech Ltd (TLV:PSRX)
61.90
0.00 (0.00%)
Nov 12, 2026, 5:24 PM IST
PsyRX CNS Bio-Tech Company Description
PsyRX CNS Bio-Tech Ltd, a pharmaceutical development company, develops proprietary ibogaine-based platform for neuropsychiatric disorders.
It is developing a PSX-001 for major depressive disorder; and PSX-002 for PTSD and trauma-related disorders.
PsyRX CNS Bio-Tech Ltd was formerly known as Cannabotech LTD. The company was founded in 2019 and is based in Tel Aviv-Yafo, Israel.
PsyRX CNS Bio-Tech Ltd
| Country | Israel |
| Founded | 2019 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Itay Hecht |
Contact Details
| Phone | 972 3 5670100 |
| Website | psyrx.co |
Stock Details
| Ticker Symbol | PSRX |
| Exchange | Tel Aviv Stock Exchange |
| Reporting Currency | ILS |
| ISIN Number | IL0011769085 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Itay Hecht | Chief Executive Officer |